Optison (Human Albumin Microspheres And Perflutren) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Optison. Always confirm against the full prescribing information.
100 interactions
Adenosine
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Adenosine.
Level 2 evidence
Amifampridine
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Amifampridine.
Level 2 evidence
Amisulpride
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Amisulpride.
Level 1 evidence
Amitriptyline
The risk or severity of QTc prolongation can be increased when Amitriptyline is combined with Perflutren.
Level 2 evidence
Atropine
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Atropine.
Level 2 evidence
Azithromycin
The risk or severity of QTc prolongation can be increased when Azithromycin is combined with Perflutren.
Level 2 evidence
Bedaquiline
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Bedaquiline.
Level 1 evidence
Berotralstat
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Berotralstat.
Level 2 evidence
Carbinoxamine
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Carbinoxamine.
Level 2 evidence
Ceritinib
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Ceritinib.
Level 2 evidence
Chloroquine
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Chloroquine.
Level 2 evidence
Chlorpheniramine
The risk or severity of QTc prolongation can be increased when Perflutren is combined with Chlorpheniramine.
Level 2 evidence
Enter your NPI to unlock 15 major interactions for Optison
Optison (Human Albumin Microspheres And Perflutren) has 253 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Optison (Human Albumin Microspheres And Perflutren) has 41 major, 83 moderate, and 129 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Optison. Always confirm against the full prescribing information.